Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung
针对IV期及复发性难治性肺腺癌的一线治疗,个体化治疗的成本效益分析
期刊:Journal of Oncology Practice
影响因子:
doi:10.1200/JOP.2011.000502
Handorf, Elizabeth A; McElligott, Sean; Vachani, Anil; Langer, Corey J; Bristol Demeter, Mirar; Armstrong, Katrina; Asch, David A